NCT00087386 arm group 08a0240915fac2fdb6a65889e060ae80 [clinicaltrials_resource:NCT00087386/arm-group/08a0240915fac2fdb6a65889e060ae80]
NCT00087386 arm group 08a0240915fac2fdb6a65889e060ae80 [clinicaltrials_resource:NCT00087386/arm-group/08a0240915fac2fdb6a65889e060ae80]
Bio2RDF identifier
NCT00087386/arm-group/08a0240915fac2fdb6a65889e060ae80
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... a0240915fac2fdb6a65889e060ae80
description [clinicaltrials_vocabulary:description]
Patients receive tanespimycin ...... sion or unacceptable toxicity.
identifier
clinicaltrials_resource:NCT00087386/arm-group/08a0240915fac2fdb6a65889e060ae80
title
NCT00087386 arm group 08a0240915fac2fdb6a65889e060ae80
@en
type
label
NCT00087386 arm group 08a02409 ...... 0240915fac2fdb6a65889e060ae80]
@en